With improved survival rates after pediatric liver transplantation (LT), attention is targeting improving the health-related quality of life (HRQOL) as an outcome metric. We conducted a systematic review of the literature to examine HRQOL after pediatric LT, focusing on assessment tools and factors associated with HRQOL. A literature search was conducted through PubMed, Web of Science, Ovid, and Google Scholar for all studies matching the eligibility criteria between January 2004 and September 2016. Titles and abstracts were screened independently by 2 authors and consensus for included studies was achieved through discussion. A total of 25 (2 longitudinal, 23 cross-sectional) studies were reviewed. HRQOL in pediatric LT recipients is lower than healthy controls, but it is comparable to children with chronic diseases or other pediatric solid organ transplant recipients. Domain scores were lowest in school functioning on the Pediatric Quality of Life Inventory (PedsQL) Generic Core Scale 4.0 and general health perception on the Child Health Questionnaire, the 2 most commonly used generic HRQOL instruments. Identified predictors of poor HRQOL include sleep disturbances, medication adherence, and older age at transplantation. Two recently validated disease-specific HRQOL tools, Pediatric Liver Transplant Quality of Life tool and the Pediatric Quality of Life Inventory 3.0 Transplant Module, have enabled enhanced representation of patient HRQOL, when used in conjugation with generic tools. Heterogeneity in study design and instruments prevented a quantitative, meta-analysis of the data. In conclusion, continued optimization of durable outcomes for this population mandates prioritization of research focusing on the gap of targeted intervention studies aimed at specific HRQOL subdomains and longitudinal studies to predict the trajectory of HRQOL over time.
Advances in surgical, anesthetic, intensive care, and medical expertise and knowledge have directly contributed to the current status of longterm survival after liver transplantation (LT).
(1) Although LT is a lifesaving therapy, LT recipients require longterm immunosuppression, which is associated with its own morbidities. (2) Moving forward, enhancing the quality of life may be as, if not more, important than purely prolonging quantity of life years restored. (3) Health-related quality of life (HRQOL) is a multidimensional construct (4) and provides a more comprehensive evaluation than disease parameters alone, of the impact of an illness and its treatment on functioning and well-being. (5) Systematic reviews of quality of life in adult LT recipients have identified contributors to longterm outcomes. (6, 7) However, only 1 systematic review evaluating HRQOL in pediatric LT recipients has been published to date. (8) This review identified 11 peer-reviewed articles up to December 2003 and reported pediatric LT recipients have significantly lower HRQOL in comparison to healthy controls. However, the author highlighted several limitations of the then available instruments as well as methodological shortcomings of the available studies. (8) In the interim 11 years, there has been a marked increase in publications focusing on HRQOL in pediatric LT recipients along with additions to HRQOL tool armamentarium. This study aimed to review the literature to describe HRQOL after pediatric LT, focusing on assessment tools and factors associated with HRQOL.
Methods
The structure of this systematic review followed the PRISMA guidelines. (9) 
DEFINITION AND MEASUREMENT OF QUALITY OF LIFE
The World Health Organization defines quality of life as a "state of complete physical, mental, and social well-being, and not merely the absence of disease or infirmity." (10) ELIGIBILITY CRITERIA Inclusion criteria for reviewed studies are as follows:
1. Pediatric recipients of an isolated LT. 2. Validated HRQOL assessment instrument. 3. Follow-up period of at least 6 months.
These studies were restricted according to the following report characteristics: 
INFORMATION SOURCES AND SEARCH STRATEGY
An electronic database search using MEDLINE and Google Scholar was conducted to retrieve all relevant articles matching the eligibility criteria. Search words/ terms were as follows: "health related quality of life after pediatric liver transplantation," "health related quality of life in pediatric liver transplant recipients," "health related quality of life and pediatric liver transplantation," and "solid organ transplant quality of life." Reference lists from all potentially relevant articles were also examined for additional articles. The search start date was September 1, 2015 , and the close-out date was September 1, 2016.
STUDY SELECTION
Following the search, 2 reviewers (A.P. and S.M.V.) independently performed screening of titles and abstracts. Consensus for studies included for review was achieved by discussion between authors.
DATA COLLECTION AND EXTRACTION
All data items for assessment of study quality and study results were predetermined. Standardized data extraction tables were created to extract study characteristics. Following data extraction, we considered a metaanalysis to be inappropriate, due to statistical and methodological reasons, and clinical heterogeneity (diverse disease groups). Here, we present a descriptive qualitative synthesis of the evidence.
RISK OF BIAS
The Effective Public Health Practice Project (EPHPP) Quality Assessment Tool for Quantitative Studies was used independently by 2 reviewers (A.P. and S.M.V.) to systematically evaluate the quality of the included quantitative studies. This tool includes 6 components:
1. Selection bias. 2. Study design. 3. Confounders. 4. Blinding participants and investigators. 5. Validity and reliability of the data collection tools. 6. Proportion of withdrawals and drop-outs.
Each component was rated as "strong," "moderate," or "weak" based on standard criteria. (11) 
Results

STUDY SELECTION
We identified 324 articles with an additional 4 found by targeted hand searching. After removing double hits, the abstracts were screened and 27 articles were identified. An additional 2 studies were excluded, 1 because HRQOL scores were assessed in a cohort of patients who had pediatric acute liver failure without HRQOL score differentiation between patients with their native liver and those in receipt of a LT. (12) The other study was a qualitative study describing HRQOL experiences after pediatric LT. (13) A total of 25 articles were included in this review. Figure 1 provides search algorithm details. Table 1 provides quality ratings of included studies.
STUDY CHARACTERISTICS
Of the 25 studies reviewed, 19 were conducted in North America, 4 in Europe, 1 in Asia, and 1 in South America. Two studies were longitudinal, and 23 were cross-sectional studies. Six multicenter studies assessed cohort sizes ranging between 102 and 997 participants. The remaining 19 single-center studies evaluated 14-293 participants. See Table 1 for a summary of the studies reviewed.
PATIENT CHARACTERISTICS
Age at time of HRQOL evaluation ranged between 2 and 28 years. The median age at time of LT ranged between 10.3 months and 8.5 years. The most common indication for LT was biliary atresia. 
HEALTH-RELATED QUALITY OF LIFE SCORES OF PEDIATRIC LIVER TRANSPLANTATION RECIPIENTS
Pediatric Quality of Life Inventory Generic Core Scale 4.0
Among 5 multicenter studies using the PedsQL, school functioning was the lowest scoring domain, whereas physical functioning was the highest. (2, 14, 15) Scores in the school functioning domain ranged from 57.5 to 79.8. (16) (17) (18) (19) Two of these studies stratified participants according to age at testing. (16, 17) Alba et al. (16) reported mean school functioning domains scores in ages 5-7 years (57.5), 8-12 years (69.5), and 13-18 years (59.6). These self-reported scores were lower than the parent-proxy reported school functioning domain scores of 90.6 for patients aged 2-4 years. (16) Kosola et al. (17) also reported school functioning scores to be comparable to other domains in patients <7 years old (79.8 6 10.6), but the lowest of all domains (69.2 6 15.7) in patients aged 7-17 years. Two studies (17, 20) reported social functioning domain scores to be the highest of the reported scores. Table 3 summarizes studies using the PedsQL.
Child Health Questionnaire
General health perception domain scores were the lowest in all studies using the CHQ-CF87 and CHQ-PF50. (21) (22) (23) Domain scores for physical function were the highest in 2 studies, which included patients >5 years of age. (21, 24) Child Health Questionnaire (CHQ) domain scores are provided in Table 4 .
Short Form 36
SF-36 domain scores are provided in Table 5 . Two studies using the SF-36 reported physical component scores as the lowest of the domain scores. (20, 25) In contrast, Kosola et al. (17) reported physical component scores to be the highest of all domain scores at 92.7 6 12.3, higher than published US population norms (84.0 6 23.0). Table 6 summarizes the domain scores of 2 studies (26, 27) using this disease-specific module for all solid organ transplant recipients. Lowest scores were found in domains comprised of treatment (66.4 6 28.2) and anxiety (55.2 6 26.5) questions. Higher scores were seen in the about my medicines I domain, comparable to published norms of other pediatric solid organ transplant recipients (76.1 6 17.3).
Pediatric Quality of Life Inventory 3.0 Transplant Module
Pediatric Liver Transplant Quality of Life
This disease-specific tool for pediatric LT recipients was used to assess HRQOL in patients alive 15 or more years after pediatric LT, with mean total PeLTQL scores in 7 patients of 64.7 6 15.2. Mean scores of PeLTQL subdomains included future health (66.7 6 18.9), coping and adjustment (55.8 6 20.2), and social-emotional (70.6 6 16.3). (20) Infant Toddler Quality of Life Instrument ITQOL was used in 2 studies. (21, 28) A longitudinal study found ITQOL scores increased steadily 1-year after LT in all subscales except for global mental health. (28) A cross-sectional study found ITQOL scores were lower than healthy controls in the subscales of global health (85.0 versus 100.0) and general health perceptions (54.0 versus 78.0). (21) 
COMPARISON OF HEALTH-RELATED QUALITY OF LIFE SCORES IN PEDIATRIC LIVER TRANSPLANTATION RECIPIENTS TO HEALTHY CONTROLS
In 6 studies, pediatric LT recipients had lower total scores than healthy controls. (2, 15, 18, 19, 21, 29) Four studies using the PedsQL reported lower scores only on specific domains of the HRQOL measures, (20, 21, 26, 29) including the physical functioning domain scores, with scores ranging from 69.9 6 18.7 to 81.2 6 17.3. (20, 26, 29) In studies using the CHQ-PF50, the general health domain scores were significantly lower than healthy controls in 2 studies at 49.8 6 18.6 (30) and 60.3 6 13.3. (24) Four studies (18, 19, 22, 29) reported comparable domain scores to healthy controls, such as family cohesion on the CHQ-CF87 (18, 22) as well as emotional (18, 19) and physical functioning (19, 29) on the PedsQL. Total and all domain scores on the PedsQL were within normal limits and comparable to the general population in only 1 study. (27) 
COMPARISON OF HEALTH-RELATED QUALITY OF LIFE SCORES OF PEDIATRIC LIVER TRANSPLANTATION RECIPIENTS TO OTHER SOLID ORGAN TRANSPLANT RECIPIENTS
There were no significant differences noted in PedsQL scores between LT recipients (77.2 6 14.3) and renal transplant recipients (79.0 6 14.2). (31) Haavisto et al. (32) also found no significant differences in scores between liver (0.9 6 0.1), heart (0.9 6 0.1), or renal (0.9 6 0.1) transplant recipients when assessing HRQOL with the 15D-17D Standardized Healthy Utility Questionnaire.
Mohammad et al. (26) found that 20-year survivors of LT had lower scores on the PedsQL TM compared with the published reference group (5-18 years), with effect sizes ranging from 0.1 to 0.8. found heart transplant recipients reported higher mental health functioning scores compared with pediatric LT recipients on the CHQ-CF87.
COMPARISON OF HEALTH-RELATED QUALITY OF LIFE SCORES OF PEDIATRIC LIVER TRANSPLANTATION RECIPIENTS TO CHILDREN OF OTHER DISEASE GROUPS
Compared with type 1 diabetes patients, 2 studies reported significantly lower HRQOL domain scores in pediatric LT patients. (14, 22) Limbers et al. (14) reported lower total PedsQL scores (77 6 26 versus 80.8 6 12.8; (22) reported CHQ-CF87 scores to be lower in the physical function (88.6 6 14.4 versus 95.2 6 8.7; P < 0.001), role/ social-physical (86.8 6 20.5 versus 92.7 6 14.5; P < 0.05), and general health perception (54.5 6 16.6 versus 62.0 6 17.7; P < 0.001) domains.
Compared with children diagnosed with cancer, pediatric LT patients self-reported similar PedsQL scores in 3 studies. (14, 18, 26) The study by Fredericks et al. (18) noted lower school functioning domain of both the child selfreport (58.9 6 22.1 versus 68.5 6 19.7; P 5 0.049) and the parent proxy (56.6 6 21.7 versus 66.4 6 23.2; P 5 0.01) forms. Alonso et al. (15) found pediatric LT patients self-reported higher PedsQL scores in all domains, when compared with patients with childhood cancer.
Two studies compared HRQOL in pediatric LT recipients with patients with chronic liver disease. (23, 25) Duffy et al. (25) found that 20-year LT survivors (mean age 23.9 6 19.0 years) scored significantly better on the SF-36 compared with patients with chronic liver disease. (25) Gritti et al. (23) found no significant difference between the scores of recipients of pediatric LT compared with children with chronic liver disease surviving with their native liver, except in the CHQ-CF87's general health perceptions domain, where pediatric LT recipients reported lower mean scores (32.1 6 12.5 versus 44.6 6 22.4; P 5 0.03).
HEALTH-RELATED QUALITY OF LIFE SCORES IN 10-YEAR SURVIVORS OF PEDIATRIC LIVER TRANSPLANTATION
Lower physical function and physical component summary scores on the SF-36 were seen in 3 studies focusing on > 10-year survivors. (20, 25, 26) Duffy et al. (25) also found significantly lower role physical, general health, social functioning, mental health, and summary scores on the SF-36 in 20-year survivors (mean age 23.9 6 19.0 years). In contrast, Avitzur et al. (33) found the majority of 10-year survivors (mean age 18.1 6 5.2 years) self-reported their QOL as very good (mean score of 8.0 6 1.9; range, 4-10) on the Cantril's selfanchoring scale for global QOL assessment.
NONMODIFIABLE PREDICTORS OF HEALTH-RELATED QUALITY OF LIFE
Age at Health-Related Quality of Life Evaluation
Lower scores were found in older patients (>5 years) at time of QOL evaluation, (16, 17, 33, 34) most markedly in the PedsQL school functioning domain in 2 studies (see Table 3 ). (16, 17) Avitzur et al. (33) reported a trend of lower present QOL scores in younger adults (18-31 years) who had an average score of 6.6, compared with children and adolescents who had a score of 8.3 (P 5 0.07). In a multicenter cohort, PedsQL scores on the parent proxy report showed increasing age at LT was a predictor of generic HRQOL. (34) Sex Alonso et al. (34) reported that male sex was associated with lower scores on the PedsQL Cognitive Functioning Scale (odds ratio [OR], 0.5; confidence interval [CI], 0.3-0.8; P 5 0.003), (34) and Alba et al. (16) reported higher PedsQL scores in the physical (P 5 0.03) and social functioning (P 5 0.04) in female adolescents (over 13 years of age). In contrast, Cole et al. (28) reported ITQOL scores to be higher in males, in the domains of general health perception (11.2 6 3.4), global health perception (10.0 6 5.4), parental time impact (9.8 6 4.5), and parental emotional impact (14.4 6 4.5). The relationship between sex and HRQOL in pediatric LT recipients remains unclear due to inconsistent findings across the studies. (16, 28, 34) 
Social and Demographic Variables
Variables associated with HRQOL include single parent households (OR, 1.9; CI, 1.1-3.3; P 5 0.02) (34) and parental income. 
MODIFIABLE PREDICTORS OF HEALTH-RELATED QUALITY OF LIFE
Medical Status Variables
Three studies (28, 32, 34) assessed medical/health status variables of pediatric LT recipients. Details of medical status variables associated with HRQOL can be found in Table 7 .
Medication Adherence
A significant relationship between adherence and HRQOL was seen in 3 studies. (18, 24, 31) Fredericks et al. (18) found nonadherent patients (tacrolimus SD < 2.5) had significantly lower CHQ-PF50 scores. (18) In a follow-up study, Fredericks et al. (24) found significantly lower scores in nonadherent patients (tacrolimus SD < 2.0) in all domains of the CHQ-PF50, CHQCF-87, and PedsQL. A third study assessed adherence using the Medication Adherence Measure and found scores to be significantly correlated with the general health perception domain of the CHQ-CF87. (31) Details of HRQOL scores are provided in Table 7 .
Sleep Disturbances
Lower HRQOL scores were seen in pediatric LT recipients with sleep disturbances, measured with the Pediatric Sleep Questionnaire (PSQ), compared with healthy children. (27, 35, 36) Sleep disturbances were examined using the sleep-related breathing disorder (SRBD) index of the PSQ, which assesses snoring, excessive daytime sleepiness, and behavior subscales. PSQ SRBD index scores were correlated with PedsQL total scores. (27) Similarly, Fredericks et al. (35) found PSQ SRBD index scores to be correlated to PedsQL total scores, as well as PedsQL domain scores. Andersen found PSQ SRBD index and resting leg syndrome/periodic leg movement correlated to PedsQL Family Impact Module scores. (36) Details of scores are provided in Table 7 .
INTERVENTION-BASED STUDIES
Only 1 intervention study was identified. Jerson et al. (37) evaluated the effectiveness of a 6-month peermentor program intervention directed at adherence and HRQOL. After participation, there were no statistically significant differences in HRQOL between the intervention (n 5 9) and control group (n 5 13). However, clinically significant improvements in adherence were noted after participation in the program.
Discussion
HRQOL is a vital outcome parameter in evaluating the success of pediatric LT. (3) Evaluation by both generic and disease-specific tools reveals that HRQOL is impaired in pediatric LT recipients in comparison to healthy controls, but comparable to children with chronic disease and other solid organ transplant recipients. HRQOL in the pediatric LT population is also associated with medication adherence, sleep disturbances, and age at transplantation.
In our review of published studies, the 2 most commonly used generic tools to evaluate HRQOL in pediatric LT recipients were the PedsQL and the CHQ. The CHQ and PedsQL have several overlapping domains such as physical and emotional functioning. However, a key difference between the 2 tools is the inclusion of a school functioning domain on the PedsQL. School performance is an important functional outcome for pediatric LT recipients, reflective of current development and independent functioning into adulthood. (38) Contributory variables to the low school functioning scores seen in the majority of the studies using the PedsQL may include increased school absences caused by medical surveillance requirements. School functioning scores may also be related to age of the pediatric LT recipient because low scores were not seen in the preschool population (ages 2-4 years) who may be attending day care. (16) The American Association of Pediatrics has also stressed addressing educational needs in children with chronic disease, which should be an integral part of clinical care. (39) Another key difference between the tools is that the CHQ measures general health perception. General health perception is an important subdomain of HRQOL because it is often more predictive than standard clinical measures of help-seeking behavior and health service use. (40) All studies that used the CHQ measure found the general health perception domain to be lowest of all domain scores. (18, (21) (22) (23) (24) This may be because pediatric LT recipients continue to deal with the challenges of living with a chronic condition, introducing uniquely immunosuppression-related sequelae such as renal dysfunction and posttransplant lymphoproliferative disorder. (13) Since the only systematic review of HRQOL following pediatric LT was published in 2005, 2 diseasespecific questionnaires have been validated for HRQOL assessment in pediatric LT recipients. (41, 42) Disease-specific questionnaires have the advantage of offering greater sensitivity and specificity and include questions that focus on treatment-and disease-related challenges. (43) When administering both a diseasespecific and generic HRQOL measure among the same cohort, 2 studies reported lower total scores on the disease-specific tool. (20, 27) This suggests that disease-specific tools may complement the administration of generic tools to provide an enhanced representation of patient HRQOL. Newer disease-specific tools such as the PeLTQL may also be a nonstigmatizing opportunity to screen for mental health concerns including anxiety and childhood depression. (42) Prevalence rates for anxiety and depression have been reported to be as high as 17.7% in pediatric LT recipients, (44) highlighting the need for clinicians to be attentive to the mental health needs for this patient population moving forward.
Taylor et al. (8) previously reported the absence of a relationship between HRQOL and health status variables. This review identified a study by the Functional Outcomes Group who identified multiple health status predictors of HRQOL, such as taking antiseizure medication and number of hospitalization days after LT. (34) Understanding factors affecting the HRQOL of pediatric LT recipients may allow clinical care teams to target modifiable variables through intervention. An association between HRQOL and socioeconomic variables was also noted, (34) which can be particularly useful for clinicians who are aware of family demographics, to advocate for additional resources to benefit the patient.
HRQOL is also known to be poorer in patients transplanted at an older age. (5) Theorized explanations include the concept of receiving LT when the patient is more aware of the traumatic life event, (5) and that with increasing age and transition into adolescence, patients become more aware of the surveillance burdens and its interference on their daily lives. Studies focusing on > 10-year survivors of pediatric LT recipients were consistent in demonstrating impaired self-reported HRQOL compared with normative controls. (20, 25, 26, 33) An important emerging issue identified from our review is the impact of sleep disturbances on HRQOL in pediatric LT recipients. Poor sleep quality and fatigue have been previously described in adults after LT (45) but have only recently been investigated in the pediatric population. Using the PSQ, pediatric LT recipients reported more sleep disturbances such as excessive daytime sleepiness and SRBD, which were significantly correlated with reduced total HRQOL scores. (45) Sleep difficulties and poor sleep habits may also be associated with fatigue in pediatric LT recipients. (44) Fatigue has been reported to be as high as 42% in a single cohort of pediatric LT recipients, (44) adversely affecting personal relationships, (46) and potentially HRQOL in domains such as social and emotional functioning. Further large-scale studies are needed to confirm this relationship, potentially using objective measures of sleep such as polysomnography or actigraphy.
Modifiable risk factors, such as medical adherence, were reported on less frequently despite the known relationship with graft outcomes. Of the 3 studies in which medication adherence was assessed, all demonstrated a significant relationship between medical adherence and HRQOL. (18, 24, 31) Peer-mentoring models may be a feasible and efficacious approach at improving adherence, but the longterm effects of such programs have yet to be explored. (37) Additional intervention studies targeted at improving adherence in pediatric LT recipients should be considered.
REVIEW LIMITATIONS
The main limitation of this study was the inability to complete a meta-analysis due to statistical and methodological reasons as well as clinical heterogeneity. Other methodological issues in the studies reviewed made it difficult to draw conclusions such as the lack of reporting specific results (eg, total HRQOL scores, domain scores, etc.). Also, many studies relied solely on parental proxy reports to collect HRQOL scores. Discrepancies in parent and child rating of HRQOL (47) as parental perspective does not substitute for that of the child. 
Conclusion
This systematic review highlights that HRQOL is impaired in pediatric LT recipients when compared with healthy controls, but similar to HRQOL in other disease groups and solid organ transplant recipients. Disease-specific tools are now available in the armamentarium of HRQOL instruments for clinical and research use. This review also identified multiple factors associated with HROQL, such as adherence, sleep, and age at LT. Markedly lower school functioning and general health perception domain scores are also key findings.
GUIDELINES FOR FUTURE RESEARCH
This review highlights the lack of longitudinal studies assessing HRQOL in the pediatric LT population, which can help predict the trajectory of HRQOL over time. Developing interventions targeted at improving HRQOL, sleep, and adherence in the pediatric LT population is warranted. Further research in HRQOL in pediatric chronic liver disease may also be valuable, particularly for those requiring LT at an older age. Research on HRQOL at time of assessment and listing for LT may also be helpful, as symptoms of fatigue and poor school functioning are common features of chronic liver disease and indications for LT.
